Purchases and Sales Made in Q1 2024 in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN) during Q1 2024. The information is specifically focused on institutions that hold shares of Terns Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jun 02, 2025
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-362K- 93.86% |
$1.76M - $2.96M
|
23.7K
$136K
|
|
|
May 15, 2024
Q1 2024
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-1.09M- 24.17% |
$5.28M - $8.9M
|
3.41M
$19.5M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.14M- 65.98% |
$5.53M - $9.32M
|
587K
$3.36M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.14M- 65.98% |
$5.53M - $9.32M
|
587K
$3.36M
|
|
|
May 15, 2024
Q1 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-4.47M- 76.64% |
$21.7M - $36.6M
|
1.36M
$7.81M
|